NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine ...
Mind Medicine Australia clinic joins Psyence BioMed’s expanding network of clinical sites as enrollment accelerates in the landmark Phase IIb study for Adjustment Disorder in palliative care This ...
NEW YORK, Nov. 06, 2025 (GLOBE NEWSWIRE) — Psyence Biomedical Ltd. (Nasdaq: PBM) (“Psyence BioMed” or the “Company”), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine ...
(MENAFN- GlobeNewsWire - Nasdaq) Mind Medicine Australia clinic joins Psyence BioMed's expanding network of clinical sites as enrollment accelerates in the landmark Phase IIb study for Adjustment ...
Mind Medicine Australia clinic joins Psyence BioMed’s expanding network of clinical sites as enrollment accelerates in the landmark Phase IIb study for Adjustment Disorder in palliative care NEW YORK, ...
Orchestra BioMed Holdings Inc, a biomedical company accelerating high-impact technologies to patients through strategic partnerships with market-leading global medical device companies, announced the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback